Diabetes drug may protect against kidney inflammation

A new Northwestern Medicine study has shed light on how a class of diabetes drugs may protect the kidneys—not just by lowering blood sugar, but by triggering a molecular shift that dampens inflammation, according to a study ...

FDA approves Empaveli for rare kidney diseases

The U.S. Food and Drug Administration has approved Apellis Pharmaceuticals' Empaveli (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN).

AI can help detect kidney cancer faster

Researchers have developed an AI-based tool that accelerates the detection of kidney cancer. Its effectiveness was validated in a study published in Communications Medicine.

page 8 from 28